BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 18342917)

  • 1. Impact of comorbidity on survival of Danish prostate cancer patients, 1995-2006: a population-based cohort study.
    Lund L; Borre M; Jacobsen J; Sørensen HT; Nørgaard M
    Urology; 2008 Dec; 72(6):1258-62. PubMed ID: 18342917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic impact of comorbidities on renal cancer, 1995 to 2006: a Danish population based study.
    Lund L; Jacobsen J; Nørgaard M; McLaughlin JK; Blot WJ; Borre M; Sørensen HT
    J Urol; 2009 Jul; 182(1):35-40; discussion 40. PubMed ID: 19450859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Charlson comorbidity score: a superior comorbidity assessment tool for the prostate cancer multidisciplinary meeting.
    Kastner C; Armitage J; Kimble A; Rawal J; Carter PG; Venn S
    Prostate Cancer Prostatic Dis; 2006; 9(3):270-4. PubMed ID: 16770340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there an optimal comorbidity index for prostate cancer?
    Alibhai SM; Leach M; Tomlinson GA; Krahn MD; Fleshner NE; Naglie G
    Cancer; 2008 Mar; 112(5):1043-50. PubMed ID: 18286512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed analysis of Charlson comorbidity score as predictor of mortality after radical prostatectomy.
    Froehner M; Koch R; Litz RJ; Oehlschlaeger S; Twelker L; Hakenberg OW; Wirth MP
    Urology; 2008 Dec; 72(6):1252-7. PubMed ID: 18723211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved survival of patients with prostate cancer in northern Denmark, 1985-2004.
    Lund L; Jacobsen J; Borre M; Larsen EH; Graversen PH; Sørensen HT; Nørgaard M;
    Scand J Urol Nephrol; 2007; 41(4):308-13. PubMed ID: 17763222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Charlson Index is associated with one-year mortality in emergency department patients with suspected infection.
    Murray SB; Bates DW; Ngo L; Ufberg JW; Shapiro NI
    Acad Emerg Med; 2006 May; 13(5):530-6. PubMed ID: 16551775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 20-Yr outcome in patients with well- or moderately differentiated clinically localized prostate cancer diagnosed in the pre-PSA era: the prognostic value of tumour ploidy and comorbidity.
    Adolfsson J; Tribukait B; Levitt S
    Eur Urol; 2007 Oct; 52(4):1028-35. PubMed ID: 17467883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of comorbidity on survival of invasive bladder cancer patients, 1996-2007: a Danish population-based cohort study.
    Lund L; Jacobsen J; Clark P; Borre M; Nørgaard M;
    Urology; 2010 Feb; 75(2):393-8. PubMed ID: 19914698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Mediterranean age-comorbidity prognostic index for survival in dialysis populations.
    Fernandez Lucas M; Teruel JL; Zamora J; Lopez Mateos M; Rivera M; Ortuno J
    J Nephrol; 2007; 20(6):696-702. PubMed ID: 18046672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990-2008.
    Land LH; Dalton SO; Jensen MB; Ewertz M
    Breast Cancer Res Treat; 2012 Feb; 131(3):1013-20. PubMed ID: 22002567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of comorbidity on treatment and prognosis of prostate cancer patients: a population-based study.
    Houterman S; Janssen-Heijnen ML; Hendrikx AJ; van den Berg HA; Coebergh JW
    Crit Rev Oncol Hematol; 2006 Apr; 58(1):60-7. PubMed ID: 16213153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer.
    Hall WH; Jani AB; Ryu JK; Narayan S; Vijayakumar S
    Prostate Cancer Prostatic Dis; 2005; 8(1):22-30. PubMed ID: 15700051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery.
    Nuttall M; van der Meulen J; Emberton M
    J Clin Epidemiol; 2006 Mar; 59(3):265-73. PubMed ID: 16488357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of comorbidity and age on survival with laryngeal cancer.
    Sabin SL; Rosenfeld RM; Sundaram K; Har-el G; Lucente FE
    Ear Nose Throat J; 1999 Aug; 78(8):578, 581-4. PubMed ID: 10485151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007).
    Nørgaard M; Jensen AØ; Jacobsen JB; Cetin K; Fryzek JP; Sørensen HT
    J Urol; 2010 Jul; 184(1):162-7. PubMed ID: 20483155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential prognostic impact of comorbidity.
    Read WL; Tierney RM; Page NC; Costas I; Govindan R; Spitznagel EL; Piccirillo JF
    J Clin Oncol; 2004 Aug; 22(15):3099-103. PubMed ID: 15284260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive validity of five comorbidity indices in prostate carcinoma patients treated with curative intent.
    Boulos DL; Groome PA; Brundage MD; Siemens DR; Mackillop WJ; Heaton JP; Schulze KM; Rohland SL
    Cancer; 2006 Apr; 106(8):1804-14. PubMed ID: 16534794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of comorbidity on colorectal cancer screening in the veterans healthcare system.
    Fisher DA; Galanko J; Dudley TK; Shaheen NJ
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):991-6. PubMed ID: 17627900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
    Yung KC; Piccirillo JF
    Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.